VTVT logo

vTv Therapeutics Inc. Class A Common Stock


VTVT: vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for diabetes. The company lead program is TTP399, an orally administered, small molecule, liver-selective glucokinase activator (GKA) that is a potential adjunctive therapy to insulin for the treatment of type 1 diabetes.


Show VTVT Financials

Consumer Interest
SEC Filings

Recent trades of VTVT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by VTVT's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of VTVT in WallStreetBets Daily Discussion


Recent insights relating to VTVT

CNBC Recommendations

Recent picks made for VTVT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VTVT

Corporate Flights

Flights by private jets registered to VTVT